Clinical Trials Directory

Trials / Terminated

TerminatedNCT01605968

A Comparative Efficacy and Safety Study Between Two Silver Containing Dressings In Post-Op Wound Healing

A Comparative Efficacy and Safety Study Between BCT Silver Bandage and Aquacel® Ag. Dressing In Obstetrical and Gynecological Post-Op Wound Healing

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Bio-medical Carbon Technology Co., Ltd. · Industry
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Study objective: The objective of this study is to evaluate through clinical criteria the clinical efficacy and safety of BCT Silver Bandage role in obstetrical and gynecological wound healing is as effective and safe as Aquacel® Ag. Dressing. Study devices: * Study device: BCT Silver Bandage * Comparator device:"ConvaTec"Aquacel® Ag Hydrofiber Dressing Study design: * Randomized, Open-label, interventional, comparative, preventive study with Blinded evaluator. * All subjects must meet all the inclusion \& exclusion criteria to enter this study in pre-operative phase. * Eligible subjects will be enrolled after a scheduled operative procedure. * There is SEVEN visits in this study (one screening eligibility phase up to 7 days before OP day, and four post-op treatment scheduled visits consisting on 1st , 3rd day, 5th day, 12th day and two follow up visit on the 28th and the 42nd post-operative day. * During each scheduled visit, each subject will have colored picture of his wound after dressing been removed, and on visit V6 for wound evaluation by blinded PI. Number of subjects: It is expected to recruit ≧150 eligible subjects. Study Duration: About eighteen month.

Conditions

Interventions

TypeNameDescription
DEVICEBCT Silver BandageActivated carbon fiber impregnated with silver particles
DEVICEAquacel® Ag. DressingAntimicrobial primary dressing incorporating the unique gelling action of Hydrofiber® Technology with ionic silver for wounds that are infected or at risk of infection.

Timeline

Start date
2012-06-01
Primary completion
2013-10-01
Completion
2014-01-01
First posted
2012-05-25
Last updated
2017-07-14

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01605968. Inclusion in this directory is not an endorsement.